Member Info for crumbs

?....

Amen to that Ruck...

If you do get that salary raise (which you deserve) I know of an investment!...good luck

Well ok German...

Germans are buying up scancell shares
http://en.boerse-frankfurt.de/stock/Scancell_Holdings-share

Well yes, that's valid too however once you start raising someones wages to stay you then have to do same for others...I will say all is not necessarily great at Immunocore at the moment there have been internal movements and talk of cut-backs.. so indeed Sam may well have been helped along in her decision with the writing is on the wall kinda mindset ... though far as we know she was not pushed but jumped...And there is no denying her pedigree she is an asset, think we can all agree with that and one that ....just saying here ... one that say a BioNtech would insist on before parting with what would be a rather big amount of money and investing in trials that it would expect to run smoothly...

On the floor beside your pram.........sorrry could not resist! Forgive me please...

I guess as a Chelsea fan he has to be optimistic lol

The worry I would have had would have been BioNtech buzzing off elsewhere... well I have been told the relationship with BioNtech is 'SOLID' ... so yeah could be a 5p or less raising could be a deal/s could be another source of funding but someone just left her job at $billion unicorn Immunocore to join scancell ... you would think seeing as she was at that company for many many years since it was even Immunocore and she helped progress and develope its Immtacs pipeline... a product of which we are told by Immunocore at least it is going commercial... so... why did she go and do that!... And why would Adrian join to progress a product through manufacturing when the company does not have the funds to trial it... mysteries of scancell!

There is no need to read between the lines , scancell will need further funding to complete trials... it is how they expect to get the funding we cannot say so like rats says your either in scancell for the potential or you are out of scancell... this is not a risk free share but the rewards could blow away current investor losses out into space! Yes, we could all end up on a caravan park too...... and this RNS has no bad IP aspects at all... moditope an expanding pipeline capable (at least preclinically) of getting to the hardest of cancers...

Scancell lauds another six months of progress
https://www.proactiveinvestors.co.uk/news/details/213702/scancell-lauds-another-six-months-of-progress-213702.html

lauds..lol

Caravans on the move!

You have mail from the postie :).... is it junk though!

The video is from last week lol not months ago...

Also, I thought it only affected applications made now not prior to shut down ones... scancell/Ichor clearly in contact with them so I would think that at least cannot be an issue

Well, chippers shares he bought are suffering ...and we know he feels our pain he told us so lol

I agree with motto TF and hope scancell have learnt that lesson by now... so as ever we wait and watch

As ever plenty going on...
note in a scancell RNS:
Karolinska BioNtech Genentech ISA
all have come into the scancell sphere - moditope- where next

Cliff Holloway:

'those answers to questions and have been relayed back to FDA'

6.15

https://www.youtube.com/watch?v=gBTaKD518yY&t=3s

there you go Gun

For appointment of Adrian:
'A defined manufacturing process is a key component for CMC (Chemistry, Manufacturing and Control) regulatory submissions required to support the filing of a clinical trial application (CTA) in the UK, toxicology studies and supply of the Modi-1 vaccine for the planned Phase 1/2 clinical study is anticipated to commence in H2 2019'

reasons for the appointment of Samantha:

will help us to further develop Moditope®, not only for use in cancer vaccines, but also other cancer immunotherapy approaches including T-cell receptor (TCR) based therapeutics which is also the subject of Scancell's research collaboration with BioNTech announced in January 2018.